Copyright Reports & Markets. All rights reserved.

Global Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Market 2026 by Company, Regions, Type and Application, Forecast to 2032

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service by Type
    • 1.3.1 Overview: Global Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Market Size by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 Global Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Consumption Value Market Share by Type in 2025
    • 1.3.3 In Vivo PK and PD Service
    • 1.3.4 PK and PD modelling
    • 1.3.5 DMPK Analysis
    • 1.3.6 Ligand-Binding
    • 1.3.7 Others
  • 1.4 Global Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Market by Application
    • 1.4.1 Overview: Global Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Market Size by Application: 2021 Versus 2025 Versus 2032
    • 1.4.2 Pharmaceutical Company
    • 1.4.3 Research Institute
    • 1.4.4 Others
  • 1.5 Global Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Market Size & Forecast
  • 1.6 Global Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Market Size and Forecast by Region
    • 1.6.1 Global Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Market Size by Region: 2021 VS 2025 VS 2032
    • 1.6.2 Global Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Market Size by Region, (2021-2032)
    • 1.6.3 North America Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Market Size and Prospect (2021-2032)
    • 1.6.4 Europe Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Market Size and Prospect (2021-2032)
    • 1.6.5 Asia-Pacific Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Market Size and Prospect (2021-2032)
    • 1.6.6 South America Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Market Size and Prospect (2021-2032)
    • 1.6.7 Middle East & Africa Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Market Size and Prospect (2021-2032)

2 Company Profiles

  • 2.1 SGS
    • 2.1.1 SGS Details
    • 2.1.2 SGS Major Business
    • 2.1.3 SGS Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Product and Solutions
    • 2.1.4 SGS Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 SGS Recent Developments and Future Plans
  • 2.2 Quanticate
    • 2.2.1 Quanticate Details
    • 2.2.2 Quanticate Major Business
    • 2.2.3 Quanticate Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Product and Solutions
    • 2.2.4 Quanticate Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 Quanticate Recent Developments and Future Plans
  • 2.3 Mercodia
    • 2.3.1 Mercodia Details
    • 2.3.2 Mercodia Major Business
    • 2.3.3 Mercodia Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Product and Solutions
    • 2.3.4 Mercodia Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 Mercodia Recent Developments and Future Plans
  • 2.4 Creative Biolabs
    • 2.4.1 Creative Biolabs Details
    • 2.4.2 Creative Biolabs Major Business
    • 2.4.3 Creative Biolabs Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Product and Solutions
    • 2.4.4 Creative Biolabs Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 Creative Biolabs Recent Developments and Future Plans
  • 2.5 Allucent
    • 2.5.1 Allucent Details
    • 2.5.2 Allucent Major Business
    • 2.5.3 Allucent Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Product and Solutions
    • 2.5.4 Allucent Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 Allucent Recent Developments and Future Plans
  • 2.6 IRBM
    • 2.6.1 IRBM Details
    • 2.6.2 IRBM Major Business
    • 2.6.3 IRBM Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Product and Solutions
    • 2.6.4 IRBM Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 IRBM Recent Developments and Future Plans
  • 2.7 Pacific BioLabs
    • 2.7.1 Pacific BioLabs Details
    • 2.7.2 Pacific BioLabs Major Business
    • 2.7.3 Pacific BioLabs Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Product and Solutions
    • 2.7.4 Pacific BioLabs Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 Pacific BioLabs Recent Developments and Future Plans
  • 2.8 Altasciences
    • 2.8.1 Altasciences Details
    • 2.8.2 Altasciences Major Business
    • 2.8.3 Altasciences Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Product and Solutions
    • 2.8.4 Altasciences Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Revenue, Gross Margin and Market Share (2021-2026)
    • 2.8.5 Altasciences Recent Developments and Future Plans
  • 2.9 Celerion
    • 2.9.1 Celerion Details
    • 2.9.2 Celerion Major Business
    • 2.9.3 Celerion Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Product and Solutions
    • 2.9.4 Celerion Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Revenue, Gross Margin and Market Share (2021-2026)
    • 2.9.5 Celerion Recent Developments and Future Plans
  • 2.10 Labcorp
    • 2.10.1 Labcorp Details
    • 2.10.2 Labcorp Major Business
    • 2.10.3 Labcorp Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Product and Solutions
    • 2.10.4 Labcorp Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Revenue, Gross Margin and Market Share (2021-2026)
    • 2.10.5 Labcorp Recent Developments and Future Plans
  • 2.11 Oncodesign Services
    • 2.11.1 Oncodesign Services Details
    • 2.11.2 Oncodesign Services Major Business
    • 2.11.3 Oncodesign Services Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Product and Solutions
    • 2.11.4 Oncodesign Services Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Revenue, Gross Margin and Market Share (2021-2026)
    • 2.11.5 Oncodesign Services Recent Developments and Future Plans
  • 2.12 Drug Development Solutions
    • 2.12.1 Drug Development Solutions Details
    • 2.12.2 Drug Development Solutions Major Business
    • 2.12.3 Drug Development Solutions Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Product and Solutions
    • 2.12.4 Drug Development Solutions Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Revenue, Gross Margin and Market Share (2021-2026)
    • 2.12.5 Drug Development Solutions Recent Developments and Future Plans
  • 2.13 CD BioSciences
    • 2.13.1 CD BioSciences Details
    • 2.13.2 CD BioSciences Major Business
    • 2.13.3 CD BioSciences Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Product and Solutions
    • 2.13.4 CD BioSciences Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Revenue, Gross Margin and Market Share (2021-2026)
    • 2.13.5 CD BioSciences Recent Developments and Future Plans
  • 2.14 Creative-Bioarray
    • 2.14.1 Creative-Bioarray Details
    • 2.14.2 Creative-Bioarray Major Business
    • 2.14.3 Creative-Bioarray Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Product and Solutions
    • 2.14.4 Creative-Bioarray Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Revenue, Gross Margin and Market Share (2021-2026)
    • 2.14.5 Creative-Bioarray Recent Developments and Future Plans
  • 2.15 Biotrial
    • 2.15.1 Biotrial Details
    • 2.15.2 Biotrial Major Business
    • 2.15.3 Biotrial Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Product and Solutions
    • 2.15.4 Biotrial Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Revenue, Gross Margin and Market Share (2021-2026)
    • 2.15.5 Biotrial Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Revenue and Share by Players (2021-2026)
  • 3.2 Market Share Analysis (2025)
    • 3.2.1 Market Share of Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service by Company Revenue
    • 3.2.2 Top 3 Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Players Market Share in 2025
    • 3.2.3 Top 6 Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Players Market Share in 2025
  • 3.3 Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Market: Overall Company Footprint Analysis
    • 3.3.1 Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Market: Region Footprint
    • 3.3.2 Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Market: Company Product Type Footprint
    • 3.3.3 Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Consumption Value and Market Share by Type (2021-2026)
  • 4.2 Global Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Market Forecast by Type (2027-2032)

5 Market Size Segment by Application

  • 5.1 Global Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Consumption Value Market Share by Application (2021-2026)
  • 5.2 Global Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Market Forecast by Application (2027-2032)

6 North America

  • 6.1 North America Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Consumption Value by Type (2021-2032)
  • 6.2 North America Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Market Size by Application (2021-2032)
  • 6.3 North America Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Market Size by Country
    • 6.3.1 North America Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Consumption Value by Country (2021-2032)
    • 6.3.2 United States Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Market Size and Forecast (2021-2032)
    • 6.3.3 Canada Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Market Size and Forecast (2021-2032)
    • 6.3.4 Mexico Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Market Size and Forecast (2021-2032)

7 Europe

  • 7.1 Europe Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Consumption Value by Type (2021-2032)
  • 7.2 Europe Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Consumption Value by Application (2021-2032)
  • 7.3 Europe Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Market Size by Country
    • 7.3.1 Europe Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Consumption Value by Country (2021-2032)
    • 7.3.2 Germany Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Market Size and Forecast (2021-2032)
    • 7.3.3 France Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Market Size and Forecast (2021-2032)
    • 7.3.4 United Kingdom Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Market Size and Forecast (2021-2032)
    • 7.3.5 Russia Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Market Size and Forecast (2021-2032)
    • 7.3.6 Italy Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Market Size and Forecast (2021-2032)

8 Asia-Pacific

  • 8.1 Asia-Pacific Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Consumption Value by Type (2021-2032)
  • 8.2 Asia-Pacific Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Consumption Value by Application (2021-2032)
  • 8.3 Asia-Pacific Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Market Size by Region
    • 8.3.1 Asia-Pacific Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Consumption Value by Region (2021-2032)
    • 8.3.2 China Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Market Size and Forecast (2021-2032)
    • 8.3.3 Japan Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Market Size and Forecast (2021-2032)
    • 8.3.4 South Korea Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Market Size and Forecast (2021-2032)
    • 8.3.5 India Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Market Size and Forecast (2021-2032)
    • 8.3.6 Southeast Asia Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Market Size and Forecast (2021-2032)
    • 8.3.7 Australia Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Market Size and Forecast (2021-2032)

9 South America

  • 9.1 South America Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Consumption Value by Type (2021-2032)
  • 9.2 South America Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Consumption Value by Application (2021-2032)
  • 9.3 South America Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Market Size by Country
    • 9.3.1 South America Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Consumption Value by Country (2021-2032)
    • 9.3.2 Brazil Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Market Size and Forecast (2021-2032)
    • 9.3.3 Argentina Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Market Size and Forecast (2021-2032)

10 Middle East & Africa

  • 10.1 Middle East & Africa Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Consumption Value by Type (2021-2032)
  • 10.2 Middle East & Africa Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Consumption Value by Application (2021-2032)
  • 10.3 Middle East & Africa Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Market Size by Country
    • 10.3.1 Middle East & Africa Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Consumption Value by Country (2021-2032)
    • 10.3.2 Turkey Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Market Size and Forecast (2021-2032)
    • 10.3.3 Saudi Arabia Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Market Size and Forecast (2021-2032)
    • 10.3.4 UAE Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Market Size and Forecast (2021-2032)

11 Market Dynamics

  • 11.1 Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Market Drivers
  • 11.2 Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Market Restraints
  • 11.3 Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry

12 Industry Chain Analysis

  • 12.1 Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Industry Chain
  • 12.2 Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Upstream Analysis
  • 12.3 Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Midstream Analysis
  • 12.4 Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service market size was valued at US$ million in 2025 and is forecast to a readjusted size of US$ million by 2032 with a CAGR of %during review period.
    Pharmacokinetics and pharmacodynamics analysis service involves studying the movement and effects of drugs within the body. Pharmacokinetics focuses on how the body processes the drug, including its absorption, distribution, metabolism, and excretion. Pharmacodynamics, on the other hand, focuses on how the drug interacts with the body and produces its desired therapeutic effects. The analysis service involves conducting experiments and analyzing data to evaluate the drug"s efficacy, dosage requirements, and possible interactions.
    This report is a detailed and comprehensive analysis for global Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service market size and forecasts, in consumption value ($ Million), 2021-2032
    Global Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service market size and forecasts by region and country, in consumption value ($ Million), 2021-2032
    Global Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service market size and forecasts, by Type and by Application, in consumption value ($ Million), 2021-2032
    Global Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service market shares of main players, in revenue ($ Million), 2021-2026
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include SGS, Quanticate, Mercodia, Creative Biolabs, Allucent, IRBM, Pacific BioLabs, Altasciences, Celerion, Labcorp, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market segmentation
    Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    In Vivo PK and PD Service
    PK and PD modelling
    DMPK Analysis
    Ligand-Binding
    Others
    Market segment by Application
    Pharmaceutical Company
    Research Institute
    Others
    Market segment by players, this report covers
    SGS
    Quanticate
    Mercodia
    Creative Biolabs
    Allucent
    IRBM
    Pacific BioLabs
    Altasciences
    Celerion
    Labcorp
    Oncodesign Services
    Drug Development Solutions
    CD BioSciences
    Creative-Bioarray
    Biotrial
    Market segment by regions, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
    South America (Brazil, Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 13 chapters:
    Chapter 1, to describe Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top players of Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service, with revenue, gross margin, and global market share of Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service from 2021 to 2026.
    Chapter 3, the Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
    Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2021 to 2032.
    Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2021 to 2026.and Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service market forecast, by regions, by Type and by Application, with consumption value, from 2027 to 2032.
    Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
    Chapter 12, the key raw materials and key suppliers, and industry chain of Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service.
    Chapter 13, to describe Pharmacokinetics (PK) and pharmacodynamics (PD) Analysis Service research findings and conclusion.

    Buy now